Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P56851 (
epididymal
)
11,273
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The plasmid-encoded gene of
xylitol dehydrogenase
from the yeast Galactocandida mastotermitis was expressed in Escherichia coli at 25 degrees C. Recombinant enzyme was isolated in 70% yield using two steps of biomimetic affinity chromatography with the dye ligand Procion Red
HE3B
immobilized onto Sepharose 4B-CL. Similar to natural enzyme, recombinant
xylitol dehydrogenase
is a functional homotetramer with a stoichiometric content of catalytic zinc in each 37-kDa subunit. Though lacking bound Mg(2+) found in
xylitol dehydrogenase
isolated from yeast cell extracts, the recombinant enzyme is as active and stable as the native enzyme. Stereospecificity of enzymic hydrogen transfer from NADH has been determined by 1H-NMR and is 4-pro-R. A detailed steady-state kinetic analysis has been carried out for the enzymic reaction, polyol+NAD(+)<-->ketose+NADH+H(+), at pH 7.5 and 25 degrees C using xylitol and D-xylulose, the physiological polyol-ketose pair, as well as D-sorbitol and D-fructose. Primary deuterium kinetic isotope effects on steady-state kinetic parameters for oxidation of D-sorbitol and reduction of D-fructose have been measured at pH 7.5. Combined results of initial-rate analysis and isotope effect studies suggest that the enzyme utilizes a preferentially ordered kinetic mechanism in which NAD(+) binds before D-sorbitol and D-fructose is released before NADH. Dissociation of NADH appears to be the main rate-limiting step for D-sorbitol oxidation under substrate-saturated reaction conditions.
...
PMID:Characterization of recombinant xylitol dehydrogenase from Galactocandida mastotermitis expressed in Escherichia coli. 1260 39